368833-95-8 Usage
Uses
Used in Pharmaceutical Industry:
1H-Imidazole-4-carboxaldehyde, 1,5-dimethyl(9CI) is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 1H-Imidazole-4-carboxaldehyde, 1,5-dimethyl(9CI) is employed as a precursor in the creation of agrochemicals, which are essential for enhancing crop protection and yield.
Used in Antimicrobial Applications:
1H-Imidazole-4-carboxaldehyde, 1,5-dimethyl(9CI) is utilized as an antimicrobial agent due to its potential antifungal and antibacterial properties, making it a valuable component in the development of treatments for various microbial infections.
Used in Heterocyclic Chemistry:
1H-Imidazole-4-carboxaldehyde, 1,5-dimethyl(9CI) is used as a building block in the preparation of imidazoles, which are important heterocyclic compounds found in many biologically active molecules, playing a crucial role in the advancement of heterocyclic chemistry and its applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 368833-95-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,8,8,3 and 3 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 368833-95:
(8*3)+(7*6)+(6*8)+(5*8)+(4*3)+(3*3)+(2*9)+(1*5)=198
198 % 10 = 8
So 368833-95-8 is a valid CAS Registry Number.
368833-95-8Relevant articles and documents
COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY
-
Paragraph 00430, (2016/10/31)
Compounds and methods of modulating 15-PGDH activity, modulating tissue prostaglandin levels, treating disease, diseases disorders, or conditions in which it is desired to modulate 15-PGDH activity and/or prostaglandin levels include 15-PGDH inhibitors described herein.
Novel farnesyl protein transferase inhibitors as antitumor agents
-
Page 468, (2010/02/07)
Disclosed are novel tricyclic compounds represented by the formula (1.0): and a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for inhibiting farnesyl protein transferase. Also disclosed are pharmaceutical compositions comprising compounds of formula 1.0. Also disclosed are methods of treating cancer using the compounds of formula 1.0.